Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$2.05 USD
-0.11 (-5.09%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.06 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRDF 2.05 -0.11(-5.09%)
Will CRDF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRDF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRDF
Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know
CRDF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Should You Buy?
Other News for CRDF
Crossed Above 20 Day Moving Average appears for CRDF after 7.46% move
Is CRDF gathering momentum? Bollinger Band Squeeze shows up after climbing 0.5%
Bollinger Band Squeeze appears for CRDF after 1.96% move
The technical outlook for CRDF is unchanged after it falls 0.49% on September 15
NR7 appears for CRDF after 1.44% move